Dogwood Therapeutics, Inc. (DWTX)
4.16
+0.02
(+0.48%)
USD |
NASDAQ |
Dec 31, 16:00
4.08
-0.08
(-1.92%)
Pre-Market: 08:48
Dogwood Therapeutics Shareholders Equity (Quarterly): 77.39M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bicara Therapeutics, Inc. | 402.78M |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 91.99M |
| Total Liabilities (Quarterly) | 14.61M |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 4.488 |
| Net Debt Paydown Yield | -0.20% |